Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion
Ginsenosides are a class of natural steroid glycosides and triterpene saponins found in Panax ginseng. After screening of a commercial ginsenoside compound library for low cellular cytotoxicity and the ability to mediate efficient reductions in hepatitis B virus (HBV) mRNA expression levels in HepG2...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022017534 |
| _version_ | 1811180906625368064 |
|---|---|
| author | Ganesh Selvaraj Duraisamy Eunji Jo Ivana Huvarová Kyu-Ho P. Park Zbyněk Heger Vojtěch Adam Daniel Růžek Marc P. Windisch Andrew D. Miller |
| author_facet | Ganesh Selvaraj Duraisamy Eunji Jo Ivana Huvarová Kyu-Ho P. Park Zbyněk Heger Vojtěch Adam Daniel Růžek Marc P. Windisch Andrew D. Miller |
| author_sort | Ganesh Selvaraj Duraisamy |
| collection | DOAJ |
| description | Ginsenosides are a class of natural steroid glycosides and triterpene saponins found in Panax ginseng. After screening of a commercial ginsenoside compound library for low cellular cytotoxicity and the ability to mediate efficient reductions in hepatitis B virus (HBV) mRNA expression levels in HepG2.2.15 cells, three ginsenosides (Rg6, Rh4, and Rb3) are selected. Thereafter, using the same cellular model, all three ginsenosides are shown to mediate efficient, selective inhibition of HBV mRNA expression levels, and also interfere with the secretion of both HBV particles and hepatitis B surface antigen (HBsAg). Drug combination studies are performed in both HepG2.2.15 and HBV-infected HepG2-NTCPsec+ cell models with the selected ginsenosides and lamivudine (LMV), a nucleoside analogue used to treat chronic hepatitis B (CHB) infections. These studies, involving RT-qPCR and ELISA, suggest that Rh4/LMV combinations in particular act synergistically to inhibit the secretion of HBV particles and HBsAg. Therefore, on the assumption that appropriate in vivo data are in future agreement, Rh4, in particular, might be used in combination with nucleoside/nucleotide analogues (NUCs) to devise an effective, cost-efficient combination therapy for the treatment of patients with CHB infections. |
| first_indexed | 2024-04-11T09:10:38Z |
| format | Article |
| id | doaj.art-a8de4d1d5ad84c698c444ee4e38e4f30 |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-04-11T09:10:38Z |
| publishDate | 2022-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-a8de4d1d5ad84c698c444ee4e38e4f302022-12-22T04:32:31ZengElsevierHeliyon2405-84402022-09-0189e10465Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretionGanesh Selvaraj Duraisamy0Eunji Jo1Ivana Huvarová2Kyu-Ho P. Park3Zbyněk Heger4Vojtěch Adam5Daniel Růžek6Marc P. Windisch7Andrew D. Miller8Veterinary Research Institute, Hudcova 296/70, CZ-621 00, Brno, Czech RepublicApplied Molecular Virology Laboratory, Institut Pasteur Korea, 696 Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, South KoreaVeterinary Research Institute, Hudcova 296/70, CZ-621 00, Brno, Czech RepublicScreening Discovery Platform, Institut Pasteur Korea, 696 Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, South KoreaDepartment of Chemistry and Biochemistry, Mendel University in Brno, Zemědělská 1665/1, CZ-613 00, Brno, Czech RepublicDepartment of Chemistry and Biochemistry, Mendel University in Brno, Zemědělská 1665/1, CZ-613 00, Brno, Czech RepublicVeterinary Research Institute, Hudcova 296/70, CZ-621 00, Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 1160/31, CZ-370 05, České Budějovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 735/5, CZ-625 00, Brno, Czech RepublicApplied Molecular Virology Laboratory, Institut Pasteur Korea, 696 Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea; Division of Bio-Medical Science and Technology, University of Science and Technology, Daejeon, South Korea; Corresponding author.Veterinary Research Institute, Hudcova 296/70, CZ-621 00, Brno, Czech Republic; Department of Chemistry and Biochemistry, Mendel University in Brno, Zemědělská 1665/1, CZ-613 00, Brno, Czech Republic; KP Therapeutics (Europe) s.r.o., Purkyňova 649/127, CZ-612 00, Brno, Czech Republic; Corresponding author.Ginsenosides are a class of natural steroid glycosides and triterpene saponins found in Panax ginseng. After screening of a commercial ginsenoside compound library for low cellular cytotoxicity and the ability to mediate efficient reductions in hepatitis B virus (HBV) mRNA expression levels in HepG2.2.15 cells, three ginsenosides (Rg6, Rh4, and Rb3) are selected. Thereafter, using the same cellular model, all three ginsenosides are shown to mediate efficient, selective inhibition of HBV mRNA expression levels, and also interfere with the secretion of both HBV particles and hepatitis B surface antigen (HBsAg). Drug combination studies are performed in both HepG2.2.15 and HBV-infected HepG2-NTCPsec+ cell models with the selected ginsenosides and lamivudine (LMV), a nucleoside analogue used to treat chronic hepatitis B (CHB) infections. These studies, involving RT-qPCR and ELISA, suggest that Rh4/LMV combinations in particular act synergistically to inhibit the secretion of HBV particles and HBsAg. Therefore, on the assumption that appropriate in vivo data are in future agreement, Rh4, in particular, might be used in combination with nucleoside/nucleotide analogues (NUCs) to devise an effective, cost-efficient combination therapy for the treatment of patients with CHB infections.http://www.sciencedirect.com/science/article/pii/S2405844022017534GinsenosideHepatitis B virusLamivudineNucleoside/nucleotide analoguesHepatitis B surface proteinHepatitis B surface antigen |
| spellingShingle | Ganesh Selvaraj Duraisamy Eunji Jo Ivana Huvarová Kyu-Ho P. Park Zbyněk Heger Vojtěch Adam Daniel Růžek Marc P. Windisch Andrew D. Miller Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion Heliyon Ginsenoside Hepatitis B virus Lamivudine Nucleoside/nucleotide analogues Hepatitis B surface protein Hepatitis B surface antigen |
| title | Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion |
| title_full | Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion |
| title_fullStr | Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion |
| title_full_unstemmed | Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion |
| title_short | Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion |
| title_sort | selected ginsenosides interfere efficiently with hepatitis b virus mrna expression levels and suppress viral surface antigen secretion |
| topic | Ginsenoside Hepatitis B virus Lamivudine Nucleoside/nucleotide analogues Hepatitis B surface protein Hepatitis B surface antigen |
| url | http://www.sciencedirect.com/science/article/pii/S2405844022017534 |
| work_keys_str_mv | AT ganeshselvarajduraisamy selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT eunjijo selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT ivanahuvarova selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT kyuhoppark selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT zbynekheger selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT vojtechadam selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT danielruzek selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT marcpwindisch selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion AT andrewdmiller selectedginsenosidesinterfereefficientlywithhepatitisbvirusmrnaexpressionlevelsandsuppressviralsurfaceantigensecretion |